GI & Endoscopy

Entera Health Presents Possible New IBS Therapy

At the Experimental Biology 2013 meeting held in Boston April 20 to 24, Entera Health presented nonclinical studies demonstrating oral serum-derived bovine immunoglobulin/protein isolate (SBI) as a promising treatment for irritable bowel syndrome.

Carrie Pallardy

Tuesday, April 30th, 2013

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

SBI promotes bone density and lean body mass growth, allowing for increased nutrient absorption.

Entera Health is a biotherapeutics company focused on developing treatments for gastroenterology, oncology and immune disorder conditions.

More Articles on Gastroenterology:
Innotex Receives Patent for Colon Cancer Suturing System
Heartland Regional Medical Center Opens Gastroenterology & Hepatology Clinic
Ferring Pharmaceuticals Launches Colon Cancer Awareness Campaign

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a…

By: Sophie Eydis
2 days ago
Gastroenterologist pay breakdown in 10 stats

As of Dec. 14, gastroenterologists’ average annual salary is $583,380, according to salary transparency platform Marit Health’s compilation of 215…

By: Patsy Newitt
2 days ago
5 GI leaders on what’s changing in colonoscopy

Colonoscopy remains a cornerstone of colorectal cancer prevention, but GI leaders say the procedure’s role, and the business model built…

By: Patsy Newitt
2 days ago

Comments are closed.

From acceleration to accountability: What safe, transparent AI looks like in healthcare

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

Gastroenterologist pay breakdown in 10 stats

5 GI leaders on what’s changing in colonoscopy

Join the 40,000+ ASC leaders who start their day with Becker's